An anti-cancer gel promises to wipe out glioblastoma permanently, a feat that’s never been accomplished by any drug or surgery. So what makes this gel so special?
Scientists at Johns Hopkins University (JHU) have developed a novel gel that both eliminates brain cancer (glioblastoma) and keeps it from recurring. When they tested this anti-cancer gel on mice with glioblastoma, surprisingly, all the mouse models were cured of the illness.
“We don’t usually see 100% survival in mouse models of this disease,” said Betty Tyler, one of the study authors and a neurosurgery professor at the Johns Hopkins School of Medicine.
A report from the National Tumor Society reveals that every year over 10,000 people die of glioblastoma in the US, making it one of the deadliest cancer types.
The JHU team claims that their gel is arguably the most effective glioblastoma treatment yet developed. Since it can stop tumor growth even in parts of the brain where traditional anti-cancer medications and surgeries don’t work.
What makes the gel so effective against brain cancer?
Currently, an FDA-approved brain implant called Gliadel is considered the most popular and potent glioblastoma treatment application. Professor Tyler who played an important role in the development of Gliadel in the 1990s suggests that during the mice trials, the new gel delivered results that are even more impressive than what is achieved with Gliadel.
This is probably because the gel-based treatment features characteristics of both chemotherapy and immunotherapy. It was developed by combining an anti-cancer drug called paclitaxel with an antibody named aCD47.
The former is a chemotherapy medication used in the treatment of ovarian, lung, and breast cancer, and the latter attacks macrophages (cells that promote tumor growth by protecting cancer cells).
During the study, the researchers first surgically removed brain tumors in mice and then filled the grooves that previously contained the tumors with the gel. They noticed that the gel didn’t allow any tumor growth further in mice brains.
Moreover, when the researchers tried to manually implant glioblastoma tumors in the mice, the immune system of the animals eliminated the implanted cancer cells without any medicine or therapies. The gel suppressed the existing cancer cells and enhanced the immune system in mouse models such that no new cancer cell was allowed to grow or multiply.
Surgery is a must for the success of the gel
Glioblastoma was completely eradicated in all the mice models whose brains received the gel treatment after the surgical removal of tumors. According to Tyler, “The gel is implanted at the time of tumor resection, which makes it work really well.”
Interestingly, the factor suggested by Tyler also acts as a limitation of this treatment as the gel has been found to not work well in the absence of surgery. For instance, when the researchers applied the gel directly to tumor sites in the brain of some mice (without removing the tumors), only 50 percent of those subjects survived.
The researchers are now planning to conduct clinical trials using their anti-cancer gel. If successful in humans, the gel will revolutionize brain cancer treatment forever. Hopefully, the gel will put an end to humanity’s search for the perfect glioblastoma treatment.
News
NIH Scientists Discover Gene Responsible for Rare Eye Disease
Findings supported by the NIH pave the way for the development of genetic testing, clinical trials, and therapies. Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a gene linked to certain [...]
Alzheimer’s Breakthrough: Synthetic THC Pill Proves Effective in Clinical Trial
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s agitation medications. A study conducted by researchers from Johns Hopkins University School of Medicine and Tufts University School of Medicine found that a pill form [...]
The Future of Rare Disease Treatment with Precision Medicine
Understanding rare diseases Rare diseases affect less than 5 people out of 10,000. However, this still amounts to about 7% of the world’s population, with over 10,000 such conditions. Almost all are genetic in [...]
Doctors issue warning for upcoming ‘tripledemic
The term ‘tripledemic’ has hit headlines this week as the NHS begins its Covid and fluvaccine roll-out for vulnerable adults. As the cold weather sets in, many of us have experienced a decline in health, and this may [...]
The FDA approved a gel that can stop bleeding from wounds in seconds
Aug 15 (Reuters) - The U.S. Food and Drug Administration has cleared Cresilon's gel to quickly control bleeding, the privately held company said on Thursday, potentially giving emergency medical technicians and combat medics a [...]
High levels of microplastics found in prostate tumors, possibly linked to take-out food
The presence of microplastics in prostate tumors points to potential health risks, and researchers are calling for urgent studies to explore how take-out food may be driving this exposure. In a recent study published [...]
AI outperforms radiologists in brain tumor diagnosis
As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct diagnosis is crucial to ensure [...]
Breakthrough Study Reveals Molecular Clues to Dementia Origins
Work could lead to the discovery of new therapeutic targets. For the first time, researchers have identified “molecular markers” linked to degeneration—detectable changes in cells and their gene-regulating networks—that are common across several types [...]
Better than blood tests? Nanoparticle potential found for assessing kidneys
In a study published July 29 in Advanced Materials, University of Texas at Dallas researchers found that X-rays of the kidneys using gold nanoparticles as a contrast agent might be more accurate in detecting kidney [...]
Greener nanomaterials could transform how our everyday stuff is made
Tiny nanoparticles are at the forefront of materials science—with special properties that make them great at absorbing light in solar panels, cleaning wastewater, and delivering drugs precisely. Some nanoparticles take the form of sheets or fibers. But nanomaterials all [...]
AI could predict breast cancer risk via ‘zombie cells’
Women worldwide could see better treatment with new AI technology, which enables better detection of damaged cells and more precisely predicts the risk of getting breast cancer, shows new research from the [...]
Through the eyes of a cat – biomimicry of feline eyes may revolutionize robotic vision
In a recent study published in the journal Science Advances, researchers leveraged crucial aspects of feline eyes, particularly their tapetum lucidum and vertically elongated pupils (VP), to develop a monocular artificial vision system capable of [...]
New Alzheimer’s Therapy Shows Remarkable Results in Animal Trials
A study from TUM demonstrates a promising therapeutic approach. Researchers at the Technical University of Munich (TUM) have made promising advances in preventing Alzheimer’s by developing a new therapeutic strategy. Their approach focuses on targeting the amyloid beta [...]
Rewriting Cancer’s Blueprint: New Study Challenges Old Theories
A new study argues for a revised clonal evolution model of cancer, incorporating genetic and non-genetic factors to improve understanding and treatment. Like all living organisms, cancer cells are driven by the fundamental need [...]
Microplastics Everywhere: Experts Demand Worldwide Treaty Before It’s Too Late
A new report calls for global action on plastic pollution, urging reductions in plastic production and microplastic emissions. Researchers stress the importance of addressing plastic pollution through both scientific and social science perspectives. A [...]
Blood tests could soon predict your risk of Alzheimer’s
Scientists are closing in on biomarkers that reflect the progression of Alzheimer’s disease and could improve treatments. Like many Alzheimer’s researchers, neurologist Randall Bateman is not prone to effusiveness, having endured disappointments in his [...]
